| abstract |
Provided herein are specific CD137 receptor agonist proteins, nucleic acids encoding the same, and methods of treating a subject having a CD137L-related disease or disorder. The CD137 receptor agonist protein provided herein comprises three soluble CD137L domains and an Fc fragment. CD137 receptor agonist proteins are substantially non-aggregating and are suitable for therapeutic, diagnostic and / or research applications. |